Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: A double-blind placebo-controlled clinical trial

Phytotherapy Research

Volumn 23, Issue 3, 2009, Pages 367-372

  Mori, Koichiro ^a,c   Inatomi, Satoshi ^a   Ouchi, Kenzi ^a   Azumi, Yoshihito ^a   Tuchida, Takashi ^b  

^a J   (Japan)

^b Isogo Central & Neurosurgical Hospital   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Dementia; HDS R; Hericium; Yamabushitake

Indexed keywords

NOOTROPIC AGENT; PLACEBO; UNCLASSIFIED DRUG; YAMABUSHITAKE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HERICIUM ERINACEUS; HUMAN; JAPANESE; MALE; MUSHROOM; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME;

AGARICALES; AGED; AGED, 80 AND OVER; COGNITION DISORDERS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS;

BASIDIOMYCOTA; HERICIUM; HERICIUM ERINACEUM;

EID: 61449242700     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2634     Document Type: Article

References (18)

1. Collerton D. 1986. Cholinergic function and intellectual decline in Alzheimer's disease. Neuroscience 19: 1-28.
2. Hashimoto M, Tanabe Y, Fujii Y, Kikuta T, Shibata H, Shido O. 2005. Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats. J Nutr 135: 549-555.
3. Imai Y, Hasegawa K. 1994. The Revised Hasegawa's Dementia Scale (HDS-R)-evaluation of its usefulness as a screening test for dementia. Hong Kong J Psychiatry 4: 20-24.
4. Kawagishi H, Ando M, Mizuno T. 1990. Hericenone A and B as cytotoxic principles from the mushroom Hericium erinaceum. Tetrahedron Lett 31: 373-376.
5. Kawagishi H, Ando M, Sakamoto H et al. 1991. Hericenone C, D and E, stimulators of nerve growth factor (NGF) synthesis, from the mushroom Hericium erinaceum. Tetrahedron Lett 32: 4561-4564.
6. Kawagishi H, Ando M, Shinba K et al. 1993. Chromans, hericenone F, G and H from the mushroom Hericium erinaceum. Phytochemistry 32: 175-178.
7. Kawagishi H, Shimada A, Shirai R et al. 1994. Erinacines A, B and C, strong stimulators of nerve growth factor (NGF)- synthesis, from the mycelia of Hericium erinaceum. Tetrahedron Lett 35: 1569-1572.
8. Kawagishi H, Shimada A, Hosokawa S et al. 1996. Erinacines E, F, and G, stimulators of nerve growth factor (NGF)- synthesis, from the mycelia of Hericium erinaceum. Tetrahedron Lett 37: 7399-7402.
9. Kawagishi H, Ishiyama D, Mori H et al. 1997. Dictyophorines A and B, two stimulators of NGF-synthesis from the mushroom Dictyophora indusiata. Phytochemistry 45: 1203-1205.
10. Kim KW, Lee DY, Jhoo JH et al. 2005. Diagnostic accuracy of mini-mental status examination and revised Hasegawa dementia scale for Alzheimer's disease. Dement Geriatr Cogn Disord 19: 324-330.
11. Lee EW, Shizuki K, Hosokawa S et al. 2000. Two novel diterpenoids, erinacines H and I from the mycelia of Hericium erinaceum. Biosci Biotechnol Biochem 64: 2402-2405.
12. Lim GP, Calon F, Morihara T et al. 2005. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 25:3032-3040.
13. Luchsinger JA, Mayeux R. 2004. Dietary factors and Alzheimer's disease. Lancet Neurol 3: 579-587.
14. Mattson MP. 2003. Gene-diet interactions in brain aging and neurodegenerative disorders. Ann Intern Med 139: 441-444.
15. Maurer K, Ihl R, Dierks T, Frolich L. 1997. Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type. J Psychiatr Res 31: 645-655.
16. Obara Y, Nakahata N, Kita T et al. 1999. Stimulation of neurotrophic factor secretion from 1321N1 human astrocytoma cells by novel diterpenoids, scabronines A and G. Eur J Pharmacol 370: 79-84.
17. Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT. 1998. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology 50: 136-145.
18. Takei N, Tsukui H, Hatanaka H. 1989. Intracellular storage and evoked release of acetylcholine from postnatal rat basal forebrain cholinergic neurons in culture with nerve growth factor. J Neurochem 53: 1405-1410.